Lisata Therapeutics (LSTA) Stock Price, Quote, News & History | Benzinga

Lisata Therapeutics Inc (LSTA) Stock Price, Quote, News & History

LSTANASDAQ

Trade with Public

Trade with Public

$1.55

0.4338.39%

At close: Aug 21, 5:00 PM EST

$1.64

0.095.81%

After Hours: Aug 21, 7:59 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Stock Report

Key Statistics

Open

$1.11

Close

$1.55

Volume / Avg.

7.12M / 127.81K

Day Range

$1.10 - $1.79

52 Wk Range

0.99 - 5.07

Market Cap

$14.78M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

0.76%

Days to Cover

1

Recent Lisata Therapeutics Inc News

Lisata Therapeutics Stock Falls After Hours: Here's Why

Lisata Therapeutics stock fell after hours after updating investors on its pending acquisition and tender offer.

Tanya Rawat

Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announced to acquire the homebuilder.

Avi Kapoor

Why Lisata Therapeutics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken private by Kuva Labs for $5.00 per share + $1.00 CVR.

Avi Kapoor

Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates

Avi Kapoor

Why Is Lisata Therapeutics Stock Gaining Today?

Lisata Therapeutics shares surged premarket after Kuva Labs agreed to acquire the company for $4 per share in cash plus two milestone-based CVRs.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.32M

Investing Cash Flow (TTM)

5.15M

Financing Cash Flow (TTM)

768.00K

Free Cash Flow (TTM)

-12.32M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-6.41M

Analyst Trends and Forecast

1

May

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$8.00M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

99.83

PB Ratio (TTM)

1.22

Earnings Yield % (TTM)

-146.43%

Earnings Yield % (FWD)

-97.32%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.91

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$10.44M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.11

Close

$1.55

Volume / Avg.

7.12M / 127.81K

Day Range

$1.10 - $1.79

52 Wk Range

0.99 - 5.07

Market Cap

$14.78M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

0.76%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Lisata Therapeutics (LSTA) stock?

A

You can purchase shares of Lisata Therapeutics (NASDAQ:LSTA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lisata Therapeutics (LSTA) competitors?

A

Other companies in Lisata Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Lisata Therapeutics (LSTA) stock?

A

There is no analysis for Lisata Therapeutics to provide a consensus price target.

Q

What is the current price for Lisata Therapeutics (LSTA)?

A

The stock price for Lisata Therapeutics (NASDAQ: LSTA) is $1.64 last updated August 21, 2026 at 7:59 PM EDT.

Q

Does Lisata Therapeutics (LSTA) pay a dividend?

A

There are no upcoming dividends for Lisata Therapeutics.

Q

When is Lisata Therapeutics (NASDAQ:LSTA) reporting earnings?

A

Lisata Therapeutics does not have any upcoming earnings scheduled.

Q

Is Lisata Therapeutics (LSTA) going to split?

A

There is no upcoming split for Lisata Therapeutics.

Q

What sector and industry does Lisata Therapeutics (LSTA) operate in?

A

Lisata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.